Canada Liver Diseases Therapeutics Market Analysis

Canada Liver Diseases Therapeutics Market Analysis


$ 3999

Canada's liver disease therapeutics market is likely to grow at a CAGR of 5.7% from a market size of $1.84 Bn in 2022 to $2.87 Bn in 2030. The increase in alcohol consumption along with the change in lifestyle and increasing geriatric population acts as a market growth driver. This report is segmented by treatment type, disease type, and by distribution channel. Some key players in this market include AbbVie, Novartis, Bristol-Myers & Squibb, Merck, Roche, Eli Lilly, and others.

ID: IN10CAPH040 CATEGORY: Pharmaceuticals GEOGRAPHY: Canada AUTHOR: Dhruv Joshi

Buy Now

Canada Liver Disease Therapeutics Market executive summary

Canada's liver disease therapeutics market size is at around $1.84 Bn in 2022 and is projected to reach $2.87 Bn in 2030, exhibiting a CAGR of 5.7% during the forecast period 2022-2030. Canada is one of the biggest nations in the world and the biggest in the western hemisphere. It boasts a thriving free-market economy with companies ranging from tiny owner-managed businesses to global corporations. Canada's economy has historically been based on the export of agricultural commodities, especially grain, as well as the production and sale of natural resource exports including minerals, oil and gas, and forest products.

canada liver disease therapeutics market analysis

Market Dynamics

Market Growth Drivers

Alcohol consumption and an unhealthy lifestyle are the main causes of the rising prevalence of liver disorders such as non-alcoholic fatty liver disease (NAFLD), liver cirrhosis, hepatitis, and liver cancer worldwide. Moreover, an increase in the elderly population around the world contributes to disease dysfunction. As a result, there has been an increase in hospital admissions for both hereditary genetic illnesses and the different liver diseases indicated above. One of the main causes of liver problems is a significant increase in alcohol use since it causes certain liver cells to die during the alcohol-filtering process, which results in the accumulation of scar tissue in the liver. Although the liver may grow new cells, excessive drinking can hinder this process and increase the risk of irreversible damage. Although the liver may grow new cells, excessive drinking can hinder this process and increase the risk of irreversible damage. Alcoholic fatty liver, alcoholic hepatitis, and alcoholic cirrhosis are the three liver conditions associated with heavy drinking and are together referred to as alcohol-related liver disease or alcoholic liver disease.

Poor eating habits and an unhealthy lifestyle also contribute to weight increase, which furthers the development of obesity. The two main factors contributing to fatty liver disease in adulthood are obesity and alcoholism. As a result of being overweight or obese, fat builds up in the liver. This results in persistent inflammation and liver scarring (also known as cirrhosis). Obesity and non-alcoholic fatty liver disease are closely related. Excess fat leads to insulin resistance and inflammatory signals.

Market Restraints

The Canadian market for liver disease is constrained by a number of factors. The following are some of the major elements influencing this market's expansion: Inadequate knowledge: There is a dearth of knowledge regarding liver illnesses, their symptoms, and the available therapies among the general public. This makes it challenging for pharmaceutical companies to advertise their goods and connect with potential customers. The high treatment costs also hamper the market growth. Treating liver illnesses can be expensive, especially when they are in advanced stages. For patients who might not be able to pay for the treatments, this can be a significant obstacle.

Competitive Landscape

Key Players

  • AbbVie
  • Bristol-Myers & Squibb Company
  • Novartis
  • Merck
  • Roche
  • Eli Lilly
  • Gilead
  • Sanofi

Healthcare Policies and Regulatory Landscape

Health Canada, which is in charge of regulating and approving medications and medical equipment, is in charge of Canada's healthcare regulations for liver illnesses. Prior to being certified for use in Canada, Health Canada verifies that all medications and medical devices are secure, efficient, and of the highest caliber. Another agency that is vital to Canada's regulation of healthcare is the Canadian Agency for Drugs and Technologies in Health (CADTH). To evaluate the effectiveness of new pharmaceuticals and medical equipment from a clinical and financial standpoint, CADTH performs health technology assessments. These evaluations aid in decision-making regarding the treatments that will be covered by government and private insurance programs. In addition, the Canadian Liver Foundation (CLF) is a nonprofit group that supports and educates patients with liver illnesses as well as promotes liver health. Research into the causes and cures for liver illnesses is also supported by the CLF. In general, the regulatory policy in Canada for liver illnesses aims to guarantee that patients have access to safe and efficient therapies and that the healthcare system is capable of providing these treatments in a way that is both efficient and affordable.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Canada Liver Disease Therapeutics Segmentation

By Treatment Type (Revenue, USD Billion):

  • Chemotherapy
  • Antiviral Drugs
  • Vaccines
  • Immunosuppressants
  • Corticosteroids
  • Immunoglobulins
  • Targeted Therapy

By Disease Type (Revenue, USD Billion):

  • Non-alcoholic Fatty Liver Disease (NAFLD)
  • Autoimmune Diseases
  • Cancer
  • Hepatitis
  • Genetic Disorder
  • Others

By Distribution Channel (Revenue, USD Billion):

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Insights10 will provide you with the reports within 10 key parameters which are:

  1. Market Overview
  2. Market Growth Drivers & Restraints
  3. Epidemiology of Disease Type
  4. Market Segmentation
  5. Market Share
  6. Competitive Landscape
  7. Key Company Profiles
  8. Healthcare Policies & Regulatory Framework
  9. Reimbursement Scenario
  10. Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

 

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

 

 

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and  Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.

 

 

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing the regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue/volume
  • ​Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy of this report, please complete the form below.


We value your inquiry and offer free customization with every report to fulfil your exact research needs.


This report addresses

  • Intelligent insights to take informed business decisions
  • Qualitative, acute and result oriented market analysis
  • Market size and forecasts from 2022 to 2030
  • Opportunities for expansion and in-depth market analysis
  • Segmentation and regional revenue forecasts
  • Analysis of the market share and competitive landscape
  • Strategic Recommendations to chart future course of action
  • Comprehensive Market Research Report in PDF and PPT formats

Need more?

  • Ask our analyst how this study was put together to learn more
  • Discuss additional requirements as part of the free customisation
  • Add more countries or regions to the scope 
  • Get answers to specific business questions 
  • Develop the business case to launch the product
  • Find out how this report may influence your business revenue
Last updated on: 29 March 2023
Updated by: Ritu Baliya

Related reports (by category)


Related reports (by geography)


subscribe to our newsletter
up